Search Results - "Spring LM"

Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer.

Authors: Spring LM Han H Liu MC et al.

Source: Nature cancer [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1138.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE; PubMed not MEDLINE

Selection biases in the systematic collection of breast biobank specimens.

Authors: Bar Y Wang GX Gioia GE et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Aug 01; Vol. 11 (1), pp. 83. Date of Electronic Publication: 2025 Aug 01.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER).

Authors: Spring LM Scarpetti L Medford AJ et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Jan 07; Vol. 11 (1), pp. 2. Date of Electronic Publication: 2025 Jan 07.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.

Authors: Wander SA Lloyd MR Keenan JC et al.

Source: The Lancet. Oncology [Lancet Oncol] 2026 May; Vol. 27 (5), pp. 580-591.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

TROP2/claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer.

Authors: Wu B Thant W Bitman E et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Apr 03; Vol. 14 (4). Date of Electronic Publication: 2026 Apr 03.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.

Authors: Medford AJ Velimirovic M Gefen Y et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Aug; Vol. 212 (3), pp. 437-447. Date of Electronic Publication: 2025 May 29.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Current landscape of sequencing ADCs in metastatic breast cancer.

Authors: McLaughlin S Ravani LV Moy B et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Dec 17; Vol. 17, pp. 17588359251396656. Date of Electronic Publication: 2025 Dec 17 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer.

Authors: Wu B Thant W Bitman E et al.

Source: BioRxiv : the preprint server for biology [bioRxiv] 2024 Dec 05. Date of Electronic Publication: 2024 Dec 05.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion.

Authors: Mortensen L Ordulu Z Dagogo-Jack I et al.

Source: The oncologist [Oncologist] 2021 Oct; Vol. 26 (10), pp. 818-824. Date of Electronic Publication: 2021 Jul 13.

Publication Type: Case Reports; Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.

Authors: Spring LM Tolaney SM Fell G et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Mar; Vol. 35 (3), pp. 293-301. Date of Electronic Publication: 2023 Dec 12.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.

Authors: Naranbhai V Pernat CA Gavralidis A et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Jan 01; Vol. 40 (1), pp. 12-23. Date of Electronic Publication: 2021 Nov 09.

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Mammography decision making: Trends and predictors of provider communication in the Health Information National Trends Survey, 2011 to 2014.

Authors: Spring LM Marshall MR Warner ET

Source: Cancer [Cancer] 2017 Feb 01; Vol. 123 (3), pp. 401-409. Date of Electronic Publication: 2016 Oct 11.

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.

Authors: Spring LM Gupta A Reynolds KL et al.

Source: JAMA oncology [JAMA Oncol] 2016 Nov 01; Vol. 2 (11), pp. 1477-1486.

Publication Type: Journal Article; Meta-Analysis; Systematic Review

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE